Atlas Trials

Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody

Clinical trial NCT01594437 · COMPLETED

Trial details

NCT number
NCT01594437
Sponsor
Theraclone Sciences, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cytomegalovirus Infections
Start date
2012-05-01
Primary completion
2012-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.